Search

Search Constraints

You searched for: Author/Creator Cuthbertson, Daniel J

Search Results

1. A randomised, controlled, double blind study to assess mechanistic effects of combination therapy of dapagliflozin with exenatide QW versus dapagliflozin alone in obese patients with type 2 diabetes mellitus (RESILIENT): study protocol. Issue 7 (20th July 2021)

3. Cardiac autonomic neuropathy and risk of cardiovascular disease and mortality in type 1 and type 2 diabetes: a meta-analysis. Issue 2 (30th December 2021)

4. Compensatory changes in energy balance during dapagliflozin treatment in type 2 diabetes mellitus: a randomised double-blind, placebo-controlled, cross-over trial (ENERGIZE)—study protocol. Issue 1 (27th January 2017)

5. Developing a toolkit for the assessment and monitoring of musculoskeletal ageing. (7th September 2018)

10. Metabolic syndrome is associated with reduced flow mediated dilation independent of obesity status. Issue 2 (1st August 2020)